Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

NCT: NCT05281757 · RECRUITING

NCT IDNCT05281757
StatusRECRUITING
Start Date2022-02-18
Completion2028-10

Brief Summary

Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)

Frequently Asked Questions

What is Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex?

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex is a clinical trial registered under NCT05281757. Current status: RECRUITING.

What is the status of NCT05281757?

The current status of NCT05281757 (Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex) is: RECRUITING.

When did Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex start?

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex started on 2022-02-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑